SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+12.43%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$565M
AUM Growth
+$565M
(-13%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-22.21%
Top 10 Holdings %
Top 10 Hldgs %
37.05%
Holding
162
New
40
Increased
21
Reduced
46
Closed
39
Top Buys
| 1 |
Gilead Sciences
GILD
|
$17.9M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$15.9M |
| 3 |
Biogen
BIIB
|
$13.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$8.86M |
| 5 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$6.96M |
Top Sells
| 1 |
Merck
MRK
|
$24.8M |
| 2 |
AbbVie
ABBV
|
$23.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$23M |
| 4 |
Johnson & Johnson
JNJ
|
$22.1M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$14.4M |
Sector Composition
| 1 | Healthcare | 65.51% |
| 2 | Technology | 5.3% |
| 3 | Industrials | 3.85% |
| 4 | Energy | 1.97% |
| 5 | Consumer Discretionary | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGR
51
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $3.35M | 0.57% |
+160,000
| New | +$3.35M |
|
52
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $3.34M | 0.57% |
48,853
| – | – |
|
|
TRVN
53
DELISTED
Trevena, Inc.
TRVN
| $3.29M | 0.56% |
549,811
+218,700
| +66% | +$1.31M |
|
|
ACOR
54
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $3.23M | 0.55% |
79,105
-120,000
| -60% | -$4.91M |
|
55
Catalyst Pharmaceutical
CPRX
$2.42B
| $3.15M | 0.54% |
1,060,000
+374,500
| +55% | +$1.11M |
|
|
MRNS
56
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.09M | 0.53% |
293,533
| – | – |
|
57
Union Pacific
UNP
$132B
| $3.06M | 0.52% |
25,689
-6,623
| -20% | -$789K |
|
58
Sangamo Therapeutics
SGMO
$161M
| $3.04M | 0.52% |
+200,000
| New | +$3.04M |
|
59
MacroGenics
MGNX
$121M
| $2.95M | 0.5% |
84,198
-23,583
| -22% | -$827K |
|
60
Arrowhead Research
ARWR
$3.84B
| $2.95M | 0.5% |
+400,000
| New | +$2.95M |
|
|
EIGR
61
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.94M | 0.5% |
150,656
-35,000
| -19% | -$685K |
|
|
SAGE
62
DELISTED
Sage Therapeutics
SAGE
| $2.92M | 0.5% |
79,724
-8,200
| -9% | -$300K |
|
|
DRNA
63
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.91M | 0.5% |
+176,802
| New | +$2.91M |
|
|
ALDR
64
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.91M | 0.5% |
100,000
-50,000
| -33% | -$1.45M |
|
65
Snap-on
SNA
$16.8B
| $2.89M | 0.49% |
21,140
+5,040
| +31% | +$689K |
|
|
ESRX
66
DELISTED
Express Scripts Holding Company
ESRX
| $2.88M | 0.49% |
+33,966
| New | +$2.88M |
|
|
NPSP
67
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $2.86M | 0.49% |
80,000
-59,420
| -43% | -$2.13M |
|
|
KERX
68
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.83M | 0.48% |
+200,000
| New | +$2.83M |
|
69
ProQR Therapeutics
PRQR
$256M
| $2.82M | 0.48% |
130,000
-70,000
| -35% | -$1.52M |
|
|
MDCO
70
DELISTED
Medicines Co
MDCO
| $2.77M | 0.47% |
+100,000
| New | +$2.77M |
|
|
OCRX
71
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.68M | 0.46% |
421,254
+100,000
| +31% | +$637K |
|
72
Arbutus Biopharma
ABUS
$753M
| $2.65M | 0.45% |
+175,000
| New | +$2.65M |
|
|
AERI
73
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.58M | 0.44% |
88,516
-75,000
| -46% | -$2.19M |
|
74
Sarepta Therapeutics
SRPT
$1.98B
| $2.53M | 0.43% |
+175,000
| New | +$2.53M |
|
75
uniQure
QURE
$954M
| $2.49M | 0.42% |
+168,415
| New | +$2.49M |
|